Adven Biotech Profile
Key Indicators
- Authorised Capital ₹ 3.50 M
as on 24-10-2024
- Paid Up Capital ₹ 3.50 M
as on 24-10-2024
- Company Age 23 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 18.14 Cr
as on 24-10-2024
- Satisfied Charges ₹ 25.07 Cr
as on 24-10-2024
- Revenue 5.54%
(FY 2023)
- Profit -23.76%
(FY 2023)
- Ebitda 8.81%
(FY 2023)
- Net Worth 1.57%
(FY 2023)
- Total Assets 0.15%
(FY 2023)
About Adven Biotech
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 M and a paid-up capital of Rs 3.50 M.
The company currently has active open charges totaling ₹18.14 Cr. The company has closed loans amounting to ₹25.07 Cr, as per Ministry of Corporate Affairs (MCA) records.
Dharam Sharma and Adesh Sharma serve as directors at the Company.
- CIN/LLPIN
U24231DL2001PTC110222
- Company No.
110222
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Mar 2001
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Adven Biotech Private Limited offer?
Adven Biotech Private Limited offers a wide range of products and services, including Homeopathic Medicines & Remedies, Homeopathic Drugs, Homoeopathic Drops, Mineral Supplement, Iron Tablet, Health Conditions, Cold & Cough, Liver Care, Hair Care, Hair Growth Supplements.
Who are the key members and board of directors at Adven Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Adesh Sharma  | Director | 28-Mar-2001 | Current |
| Dharam Sharma | Director | 28-Mar-2001 | Current |
Financial Performance of Adven Biotech.
Adven Biotech Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.54% increase. The company also saw a substantial fall in profitability, with a 23.76% decrease in profit. The company's net worth moved up by a moderate rise of 1.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adven Biotech?
In 2023, Adven Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Pratibha Garments Private LimitedActive 16 years 5 months
Dharam Sharma and Adesh Sharma are mutual person
- Adesh Softech Private LimitedActive 19 years 7 months
Dharam Sharma and Adesh Sharma are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 Oct 2022 | ₹1.17 M | Open |
Others Creation Date: 13 Aug 2021 | ₹1.10 Cr | Open |
Others Creation Date: 19 Dec 2018 | ₹16.92 Cr | Open |
How Many Employees Work at Adven Biotech?
Adven Biotech has a workforce of 136 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adven Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adven Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
